Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer. - Wikidata - wikimedia - TriplyDB

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

http://www.wikidata.org/entity/Q37975227

about

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study Focal therapy for prostate cancer: rationale and treatment opportunities.The role of focal therapy in the management of localised prostate cancer: a systematic review.[Focal prostate cancer therapy: capabilities, limitations and prospects].Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol.Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.Focal low-dose rate brachytherapy for the treatment of prostate cancer.Current trends and new frontiers in focal therapy for localized prostate cancer.Predicting prostate tumour location from multiparametric MRI using Gaussian kernel support vector machines: a preliminary study.Current status of brachytherapy for prostate cancer.Development of a registration framework to validate MRI with histology for prostate focal therapy.Focal application of low-dose-rate brachytherapy for prostate cancer: a pilot study.Focal therapy for prostate cancer: the technical challenges.Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer.Cone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients.Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer.The prostate cancer focal therapy.Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference.The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer

P2860

Q28828469-42E00251-8860-43C1-BB2A-D410E9A565F9 Q30514532-625754F3-9572-4BA2-8728-11AB28234D4E Q33702259-987DBE6A-E899-4D97-BADB-229DB815EC29 Q34266167-C7ED4583-2EE4-402F-B44D-8CFD35D56D17 Q34448994-E8D5B15E-C9E0-4E57-846E-F245A85388E7 Q37043970-5EDE65F6-2AE6-4FE4-9319-F5AEDFABD12D Q37175207-76B15FEE-7733-4939-95AB-8D0F9ACA88D4 Q37188309-74B92F42-9F77-4612-8208-DE44B3C93474 Q38139392-5DED20C5-D3B2-49FD-9A67-BA8F485B9F53 Q38436625-920AADB9-5532-4013-BB86-4F10A27E39D7 Q38766178-16569D50-C653-4A34-AADC-D749072FB515 Q39513542-A061C556-D728-44F7-B793-79783B11330E Q40247297-22728539-2CED-420B-BB08-319DD384649C Q41011798-03AB8EE5-78DF-4CC9-BA69-7359A848AA00 Q41689116-38F26E0C-B312-40C2-B38A-48A8EC5984C2 Q46494342-69DF4755-5AFB-4AF9-AA37-78EFE954F0A2 Q50896202-4182B775-9003-4C28-AE0B-F4F5D48A9FF5 Q53643281-9B21611A-6701-4044-A4C1-AE70975ABCA3 Q54996559-F009836D-3358-4846-AD2B-5C57C9D4DA59 Q55317289-54058CE7-4365-4C26-BAFC-BCE2415A02F6 Q57112397-B5C74862-B7FB-4503-A5B9-106A3E48DD12

P2860

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

http://www.wikidata.org/entity/Q37975227

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

@en

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

@nl

type

label

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

@en

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

@nl

prefLabel

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

@en

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

@nl

P1433

Q37975227-CDD0BC1B-C4EC-42B8-BD51-A276D552D193

P1476

Q37975227-C98C4ED0-5D59-4DCD-A7B8-2864A8F3DC1C

P2093

Q37975227-072E210F-9C37-4FB2-A824-42DC72E70B45

Q37975227-18A17801-337D-4FA3-B387-EEB88593EB5C

Q37975227-3E8E1C90-3D88-4A9A-8C2C-03221ED4CF8E

Q37975227-463DFECE-C795-4568-9107-301CC70ABA00

Q37975227-551AD0E9-99BF-465B-B9A5-FA02A15F0A5E

Q37975227-6E5328E8-F891-460B-B980-7706A18774EA

Q37975227-9F3AABB2-8057-4939-A2DF-F321285FB6C0

Q37975227-DD9137E8-08A6-4F5D-A0BA-A4773BCEEE22

Q37975227-EEBBEE1D-B4D2-4FE1-8CCC-7B5CF2E16251

P2860

Q37975227-0B70E6C3-5A10-41EB-B019-AF20757A7F7F

Q37975227-0BEBD46D-4340-4675-9E46-3C0C1671856A

Q37975227-141EC691-69F1-490C-9EF3-EA8EDF731FBE

Q37975227-15E5D8A3-4EF3-4CA0-854C-DDF1C69411DD

Q37975227-36118E6F-9A2D-4E51-AC19-89178D1E8172

Q37975227-47CF3C02-D620-4482-899F-50D1BDB325F1

Q37975227-47F19838-CDED-4739-A7AE-3387E64F8E1D

Q37975227-4B1C6FD6-00C0-4343-8289-6A0D883F24E4

Q37975227-54CC1EC2-409A-4A4F-B182-6FBF42072C2D

Q37975227-5B6E484E-0E18-467B-B7A6-4BB56C31AB56

P304

Q37975227-936883D5-FED7-448B-97F1-A73120773E2B

P31

Q37975227-66C86BF0-D608-47E5-AC7A-D2151CB8CEE7

P356

Q37975227-F90FFD48-0B32-4292-AE30-7176EE705963

P478

Q37975227-6E6CB011-967D-4543-B0B6-6C672EF98BB0

P50

Q37975227-9E40B3F4-8261-4D93-8124-7D6921685D69

P577

Q37975227-F5FFCDA3-7D98-4B1F-9006-F418FD5A25E7

P698

Q37975227-CD8EDFAD-935E-4A46-82A8-655FF46C1A41

P921

Q37975227-C253BA32-CCB0-4A7D-B1BE-67CB55F2BC1E

P356

J.1464-410X.2011.10825.X

P1433

BJU International

P1476

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.

@en

P2093

Bashar Al-Qaisieh

http://www.w3.org/2001/XMLSchema#string

David Bostwick

http://www.w3.org/2001/XMLSchema#string

Ferran Guedea

http://www.w3.org/2001/XMLSchema#string

Francisco Gomez Veiga

http://www.w3.org/2001/XMLSchema#string

Hashim U Ahmed

http://www.w3.org/2001/XMLSchema#string

Louise Dickinson

http://www.w3.org/2001/XMLSchema#string

Peter Grimm

http://www.w3.org/2001/XMLSchema#string

Stefan Machtens

http://www.w3.org/2001/XMLSchema#string

Stephen Langley

http://www.w3.org/2001/XMLSchema#string

P2860

Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.

Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group.

Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.

D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging.

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.

The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers.

Is it time to consider a role for MRI before prostate biopsy?

The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers.

Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy.

P304

7-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2011.10825.X

http://www.w3.org/2001/XMLSchema#string

P478

109 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22239224

http://www.w3.org/2001/XMLSchema#string

P921